01 6LA JOLLA PHARMA
01 611096983
01 6Blank
01 6Blank
01 62034-12-18
Patent Expiration Date : 2034-12-18
US Patent Number : 11096983
Drug Substance Claim :
Drug Product Claim :
Application Number : 209360
Patent Use Code : U-3211
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-12-18
Patent Expiration Date : 2034-12-18
US Patent Number : 11096983
Drug Substance Claim :
Drug Product Claim :
Application Number : 209360
Patent Use Code : U-3212
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-12-18
Patent Expiration Date : 2034-12-18
US Patent Number : 11096983
Drug Substance Claim :
Drug Product Claim :
Application Number : 209360
Patent Use Code : U-3212
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-12-18
Patent Expiration Date : 2034-12-18
US Patent Number : 11096983
Drug Substance Claim :
Drug Product Claim :
Application Number : 209360
Patent Use Code : U-3212
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-12-18
Patent Expiration Date : 2034-12-18
US Patent Number : 11096983
Drug Substance Claim :
Drug Product Claim :
Application Number : 209360
Patent Use Code : U-3211
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-12-18
Patent Expiration Date : 2034-12-18
US Patent Number : 11096983
Drug Substance Claim :
Drug Product Claim :
Application Number : 209360
Patent Use Code : U-3211
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-12-18
